Abstract
Criteria for poor responders include advanced age, previous cycle cancellation, or an abnormal ovarian reserve. The strategy proposed to improve the outcome of poor responders was growth hormone(GH). In order to verify the advantage of GH administration, we conducted a study to investigate the efficacy of co-treatment with GH in control ovarian stimulation(COS) of poor responders undergoing IVF/ET.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
